It’s a ‘Stock Picker’s Market’ — and Our AI Algorithm Spotlighted This Biotech Play

Listen to this post

U.S. stocks enjoyed one heck of a run from March 2009 to February 2020.

We’re talking about 3,999 days that delivered a 400% gain in the S&P 500.

Rising tides like that may not lift all boats – but it sure does lift most of them.

Even Bed Bath and Beyond (BBBY), which just filed for bankruptcy, climbed 246.55% during parts of that bull run.


But when it comes to investing, the real trick is making money when the tide is running against you… or what investment pros refer to as a “stock picker’s market.”

One of our newest services was designed to fill that need.

It’s called Predictive Alpha Prime and is powered by our artificial intelligence (AI) and machine-learning program called An-E.

Think of it as an AI stock picker… for a stock picker’s market.


Predictive Alpha Prime was designed to provide price forecasts for virtually any stock on the S&P 500, as well as many other popular ETFs and funds.

We want to show you how it works – and even share some of the system’s latest stock recommendations.

Because the power of Predictive Alpha Prime is truly remarkable: These trades can help you find an opportunity 21 days out, after which you can invest the proceeds in a new opportunity – and do it all again.

It’s a way of stacking win after win after win – the epitome of success in a stock picker’s market.

Avita Medical Corp. (RCEL)

Health Indicator: Green Zone

Risk: High

April 28 Closing Price: $15.52

Predictive Alpha Price Projection for May 29: $16.34

If we enter a recession and people start cutting back on spending, you can find areas to invest in by asking one question: What are products and services that people can’t live without?

One necessity is health care.

People can cut back on buying clothes or going out to eat, but when it comes to spending money on their health, there isn’t really anything to cut back on because it’s a need.

And one of the companies An-E found that fits that investable idea is Avita Medical Corp.

According to the American Burn Association, over 450,000 serious burns that require medical treatment occur in the United States each year. In some cases, previous treatments involved hours of operation and large donor skin samples.

But Avita has created a novel approach to this issue with a product that utilizes the regenerative properties of a patient’s own skin.

Its RECELL System allows health care professionals to use a patient’s own skin to regenerate the outer layer of natural skin, and it can be applied in as little as 30 minutes.

You can think of it like “spray-on skin” for the treatment of burns.

The company has a development pipeline to explore further use of its RECELL technology:


From 2021 to 2022, Avita increased total revenue by 4% and commercial revenue by 36%. Its next earnings report after market close on May 11 could provide critical information about the company’s growth trajectory.


CEO Jim Corbett expects FDA approval in June for the usage of the RECELL System for soft tissue repair and vitiligo, which he said would be “transformative” for the company.

An-E also sees big things for Avita, predicting that the stock price will trade for $16.34 on May 29.


From the closing price of $15.52 on April 28, that’s nearly a 5% increase.